Alan G. White
Ph.D., economics, University of British Columbia; M. Litt., economics and B.A., economics and mathematics, University of Dublin, Trinity College
Summary of Experience:
Dr. White focuses on antitrust, intellectual property, and tax/transfer pricing matters in a range of industries, with a particular interest in health care issues in both litigation and non-litigation matters. He has supported general commercial business litigations such as allegations of false advertising and breach of contract; investigations into alleged off-label promotion of prescription drugs; and the economic impact of generic entry and substitution. He has also analyzed economic issues relevant to class certification and quantification of damages. Dr. White has managed numerous commercial litigation matters, supporting academic and industry experts in industrial organization, statistics, health economics, and marketing. His non-litigation work has involved the development of empirical models for determining factors that may help identify patients at risk of prescription opioid abuse, as well as the estimation of societal economic costs of prescription opioid abuse. His research and publications have focused on specific health economics issues, such as the costs of abuse, as well as the theory and implementation of various price indexes. Dr. White is an adjunct faculty member in the Department of Economics at Northeastern University in Boston.